The report for Global Anti-Viral Drugs Market of Market Research Future comprises
extensive primary research along with the detail analysis of qualitative as well as
quantitative aspects by various industry experts, key opinion leaders to gain the deeper
insight of the market and industry performance. Anti-viral drugs are used to treat viral
infections and are the only agents acting against viruses as either other drugs are
ineffective or too toxic. The market segment of anti-viral drugs is driven by factors such as
rise in healthcare expenditure, growing research and development investment, emergence
of virus life-threatening diseases like bird flu, strong development pipeline and increasing
incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about
36.7 million people are suffering from HIV/AIDS with 1.1 million deaths occurring due to
AIDS-related illness the emergence of donor funding in the treatment of the disease has
also increased the demands of anti-viral drug market. Strong research pipeline coupled with
rise in research and development investment will be the market driver of the future.
The constraints on the market include side effects associated with treatment, the cost of the
therapy and poor efficacy and effectiveness of the drugs.
Market Segmentation:
Global Anti-Viral Drugs Market has been segmented on the basis of on the basis of
application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis
of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse
transcriptase inhibitors, protease inhibitors and others.
Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454 .
Key Players:
Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd.,
GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, AstraZeneca AB, Cipla
Inc. and others.
Global Anti-Viral Drugs Market:
The Global Anti-Viral Drugs Market has been evaluated as a growing market and it is
expected that the market will touch high growth figures in future. The global anti-viral drugs
market is expected to grow with CAGR of ~6.9% during the forecast period. There has been
consolidation of the market as a few players have come to dominate the market due to
acquisitions and mergers.
Regional Analysis:
Depending on geographic region, anti-viral drugs market is segmented into four key
regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the
largest market for anti-viral drugs with Europe tied for the second space. Asia Pacific region
is expected to be fastest growing region in anti-viral drugs market.